EARNING RECAP

Facebook

#FB 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q2 ex- items $1.99c est. $1.88 $16.89B est. $16.50B +1.14% ($204.66 closing price) $204.81 $197.22 FB June DAUs up 8% to 1.59B; says more than 2.1B people now use product everyday
Q1 ex- items $1.89 est. $1.63/ 85c with $3B expense for FTC matter $15.08B est. $14.97B +5.85% ($193.26 closing price) $198.48 $192.12 estimates loss from FTC inquiry at $3- $5B
#FB 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $2.38 est. $2.19 $16.64B est. $16.4B +10.82% ($166.69 closing price) $171.68 $165 93% of revenue from Mobile Ads- Q4 DAU up 9% to 1..52B; estimates 2.7B people uses its services
Q3 $1.76 est. $1.47 $13.73B est. $13.78B +3.81% ($151.79 closing) $156.40 $148.96 says 2.6B people use Facebook; Says at least 2B people use one of its services everyday
Q2 $1.74 est. $1.72 $13.2B est. $13.36B -18.96% ($176.26 closing) $180.13 $173.75 See revenue decelerating in Q3, Q4.
Q1 $1.69B est. $1.35B $11.97B est. $11.41B +9.06% ($174.16 closing) $176.27 $170.80 Q1 DAU up 13% MoM, MAU up 13% YoY;Increased buyback by additional $9B
#FB 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $1.44 VS $1.95 $12.97B VS $12.55B +3.32% $195.32 $187.89 Mark Zuckerberg: FB changes reduced time spent on site by 50 million hours a day in Q4. Says Q4 EPS lowered by 77c due to accounting bulletin
Q3 $1.59 Vs $1.28 $10.328B Vs $9.848b -2.05% (178.92 closing) $181.94 $177.34 Q3 daily active users up 16% to 1.37B.
Q2 $1.32 vs $1.13 $9.16 vs $9.2B +2.92% ($175.49 closing) $175.49 $167.50 -3.06% initial reaction to $160.02. Then pop back to +3.43% to 171.29 DAUs up 17% . Record highs print, gap up on opening& pullback throughout the day.
Q1 $1.04 vs 87c est $8.03B vs $7.84B est -0.63% ($150.85 closing) $151.52 $148.72 Added 80M new monthly active users last Q. Company no longer reporting non-GAAP ER info

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.